Gng Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.45 M
as on 18-07-2024
- Satisfied Charges ₹ 7.00 M
as on 18-07-2024
- Revenue 6.57%
(FY 2023)
- Profit 108.75%
(FY 2023)
- Ebitda 461.31%
(FY 2023)
- Net Worth 4.22%
(FY 2023)
- Total Assets -6.16%
(FY 2023)
About Gng Medical
The Corporate was formerly known as Gaharwar & Gaharwar Pharmaceuticals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.45 M. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajkumar Singh, Nirmala Singh, and Sadhana Singh serve as directors at the Company.
- CIN/LLPIN
U51397MH2009PTC198208
- Company No.
198208
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gng Medical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Singh  | Director | 30-Dec-2009 | Current |
| Nirmala Singh | Director | 30-Dec-2009 | Current |
| Sadhana Singh | Director | 30-Dec-2009 | Current |
Financial Performance of Gng Medical.
Gng Medical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.57% increase. The company also saw a substantial improvement in profitability, with a 108.75% increase in profit. The company's net worth moved up by a moderate rise of 4.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gng Medical?
In 2023, Gng Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zest Diabetes Care Private LimitedActive 5 years 11 monthsRajkumar Singh, Nirmala Singh and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Capital First Limited Creation Date: 29 Apr 2015 | ₹8.45 M | Open |
Nkgsb Co.Op. Bank Ltd. Creation Date: 05 Nov 2014 | ₹0.70 M | Satisfied |
Nkgsb Co.Op. Bank Ltd. Creation Date: 20 Feb 2013 | ₹6.30 M | Satisfied |
How Many Employees Work at Gng Medical?
Unlock and access historical data on people associated with Gng Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gng Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gng Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
